Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Card image cap

CANTON, Mass., Oct. 05, 2023 -- Organogenesis Holdings Inc. , a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the...

Related Keywords

China , Canton , Ron Obrien , Mike Piccinino , Nasdaq , Organogenesis Holdings Inc , Globenewswire Inc , Advanced Wound Care , Sports Medicine , Media Inquiries , Organogenesis Rono Brien , Markets ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.